From BioPolicyWiki
Revision as of 22:21, 21 February 2015 by Sonia Allan (Talk | contribs)

Jump to: navigation, search
Region Latin America
Population 108700891
GDP (millions USD) 893,365
National Policies
Eggs for assisted reproduction no policy
Eggs for research ?
Inheritable genetic modification ?
Preimplantation genetic diagnosis no policy
Reproductive cloning PROHIBITED
Research cloning PROHIBITED
Sex selection ?
Surrogacy commercial prohibited
International Agreements
2005 UN Cloning Vote YES
2005 UNESCO Sports Doping Convention RATIFIED


Key laws and policies

  • General Health Law (February 7, 1984, amended June 2006)[1]
  • Regulation of the General Health Law on Scientific Health Research (1985)[1]
  • Mexico is a Federal Republic, local jurisdictions have the power to regulate on family matters. As far as the Assisted Reproductive Technology (ART) is concerned,
    • there is permissive legislation in the States of Colima, Querétaro, and Tabasco;
    • there is the possibility of ART by interpretation of law in Michoacán, Morelos, Puebla, Sonora and Zacatecas;
    • prohibitive legislation in ART can be found in the States of Coahuila and San Luis Potosí.
    • there is a lack of legislation in the other States.

Article 330 of the General Health Law explicitly prohibits two things: a) To transplant gonads or gonadic tissue. b) To use, no matter for what end, any kind of embryonic or foetal tissue of induced abortions.

Prohibited practices

Reproductive and research cloning, inheritable genetic modification, and surrogacy are prohibited, at least implicitly.[2][3][4][5]

  • Commercial surrogacy is prohibited because it is seen that it may hurt the child by allowing payment to someone for being the expectant mother.
  • All arrangements related to surrogacy must be without compensation.
  • No financial remuneration at all is permitted.

Permitted and regulated practices


Providing eggs for reproduction is permitted under guidelines.[6]


There is no law or policy regarding PGD.[7]


Altruistic surrogacy has been approved in limited circumstances.


"The regulation of PGD has been subject to ample parliamentary debate, and several bills have been introduced. Most of the draft bills call for restricting use of the procedure to serious conditions and for prohibiting PGD sex selection for non-medical purposes."[1]

External links


  1. 1.0 1.1 1.2 Rosario M. Isasi and Bartha M. Knoppers, "National Regulatory Frameworks Regarding Human Reproductive Genetic Testing," A Report for the Genetics and Public Policy Center (July 2006)
  2. Genetics and Public Policy Center, "Cloning, General Health Law (Mexico)"
  3. Genetics and Public Policy Center, "Human Genetic Modification, General Health Law (Mexico)"
  4. Kathryn Wheat and Kirstin Matthews, "World Human Cloning Policies," Paper Presented at Stem Cells: Saving Lives or Crossing Lines, Houston, Texas (November 20-21, 2004)
  5. Rachel Cook, Shelley Day Sclater, and Felicity Kaganas, Surrogate Motherhood: International Perspectives, Hart Publishing (2003) p. 2
  6. American Society for Reproductive Medicine, "IFFS Surveillance 07," Fertility and Sterility (Vol. 87. No. 4, Suppl. 1, April 2007)
  7. Genetics and Public Policy Center, "Reproductive Genetic Testing, General Health Law (Mexico)"